| Expression pattern: |
UP |
| Associated gene: |
- |
| Associated microRNA: |
- |
| Biological function: |
Potential noninvasive serum biomarker for HCC diagnosis; associated with tumor size and other clinical/laboratory factors. |
| Molecular mechanism: |
Bioinformatics-based selection suggested involvement of the selected circRNA panel in Wnt signalling, IKK/NF-kappaB signaling, and cell proliferation; no experimental molecular mechanism was validated for this circRNA. |
| Biological pathway or process: |
Wnt/beta-catenin (other); NF-kappaB (other); proliferation (other) |
| Detected method: |
Q
|
| Validation methods: |
RNase R Treatment; RT-qPCR; Clinical Sample Validation; ROC Analysis; Survival Analysis; Bioinformatics Analysis |
| Clinical significance: |
Strong serum biomarker potential with relatively high sensitivity and specificity compared with AFP; associated with mean size of the tumor in the malignant group. |
| Description: |
hsa_circ_000224 was selected as part of a bioinformatics-derived serum circRNA biomarker panel and validated by RT-qPCR. It was up-regulated in HCC serum, showed strong diagnostic performance compared with AFP, and its expression was associated with tumor size and relapse-free survival patterns. |
| Confidence score: |
0.6023 |